Summary: Amends the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes. Cosponsors
ANGIE CRAIG’S POSITION: Representative Craig cosponsored the bill on 3/25/19.
STATUS: Introduced 1/31/19 by Rep. Schrader, Kurt [D-OR-5].
ORGANIZATIONS IN SUPPORT OF THE BILL:
- Check back as organizations publicly support the bill.